all report title image

Thrombin Inhibitor Market, By Type (Direct Thrombin Inhibitors and Indirect Thrombin Inhibitors), By Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation (AF), and Others (stroke prevention, acute coronary syndrome, etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In : Nov 2023
  • Code : CMI5835
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image
N/A

Table of Contents:

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Thrombin Inhibitor, By Type
      • Market Thrombin Inhibitor, By Application
      • Market Thrombin Inhibitor, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Thrombin Inhibitor Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Thrombin Inhibitor Market, By Type, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2018 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Direct Thrombin Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Indirect Thrombin Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  6. Thrombin Inhibitor Market, By Application, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2018 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • Deep Vein Thrombosis (DVT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Pulmonary Embolism (PE)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Atrial Fibrillation (AF)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Others (Stroke Prevention, Acute Coronary Syndrome, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  7. Thrombin Inhibitor Market, By Region, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2018 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019 – 2030
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • U.K.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape
    • Eisai Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis International AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Portola Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CSL Behring
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim GmbH
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Daiichi Sankyo Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Aspen Pharmacare Holdings Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section
    • Research Methodology
    • About us

*Browse 24 market data tables and 28 figures on "Global Thrombin Inhibitor Market” - forecast to 2030

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.